Share Viridian Therapeutics initiated at 'buy' by Bank of America with $47 price target

Proactive Investors · VRDN · November 19, 2026

Viridian Therapeutics initiated at 'buy' by Bank of America with $47 price target

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Proactive Investors ↗